Published in Oncogene on August 13, 2007
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell (2009) 8.69
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol (2008) 6.90
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat Biotechnol (2011) 4.83
Tubulin modifications and their cellular functions. Curr Opin Cell Biol (2008) 3.52
Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol (2008) 2.85
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc (2010) 2.50
The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev (2007) 2.43
Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J (2009) 2.37
The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res (2008) 2.17
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res (2008) 1.88
The role of HDAC6 in cancer. J Biomed Biotechnol (2010) 1.77
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Future Med Chem (2012) 1.74
Post-translational modifications of microtubules. J Cell Sci (2010) 1.72
Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. J Med Chem (2008) 1.70
Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells. Leuk Lymphoma (2011) 1.59
Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol (2010) 1.55
Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation. Am J Physiol Cell Physiol (2013) 1.53
Diversity in the origins of proteostasis networks--a driver for protein function in evolution. Nat Rev Mol Cell Biol (2013) 1.51
The tale of protein lysine acetylation in the cytoplasm. J Biomed Biotechnol (2010) 1.44
Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy. Oncogene (2011) 1.38
Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem (2008) 1.38
Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev (2012) 1.34
Post-translational modifications of tubulin: pathways to functional diversity of microtubules. Trends Cell Biol (2014) 1.33
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect. Invest New Drugs (2010) 1.27
Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS One (2011) 1.25
Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO J (2010) 1.23
Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression. Clin Cancer Res (2009) 1.23
Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol Nutr Food Res (2011) 1.22
CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin. EMBO J (2009) 1.21
Heat shock protein 90 inhibition in lung cancer. J Thorac Oncol (2008) 1.18
PKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-catenin. EMBO J (2011) 1.13
Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini. J Biol Chem (2011) 1.11
HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma. Neoplasia (2011) 1.11
Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation. Mol Biol Cell (2010) 1.10
Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates. J Biomed Biotechnol (2010) 1.08
A novel GRK2/HDAC6 interaction modulates cell spreading and motility. EMBO J (2011) 1.08
Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors. J Biomed Biotechnol (2010) 1.02
Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis. Cell Death Differ (2012) 1.00
Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR. J Biol Chem (2009) 0.99
Histone deacetylase 6 (HDAC6) deacetylates survivin for its nuclear export in breast cancer. J Biol Chem (2012) 0.96
α-Tubulin acetylation elevated in metastatic and basal-like breast cancer cells promotes microtentacle formation, adhesion, and invasive migration. Cancer Res (2014) 0.96
Extracellular signal-regulated kinase (ERK) phosphorylates histone deacetylase 6 (HDAC6) at serine 1035 to stimulate cell migration. J Biol Chem (2013) 0.95
Bioinformatic analysis of xenobiotic reactive metabolite target proteins and their interacting partners. BMC Chem Biol (2009) 0.94
Metabolism, cytoskeleton and cellular signalling in the grip of protein Nepsilon - and O-acetylation. EMBO Rep (2007) 0.94
Histone deacetylase inhibitors as novel anticancer therapeutics. Curr Oncol (2008) 0.92
A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth. Br J Cancer (2013) 0.91
PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport. Mol Endocrinol (2012) 0.90
Nitric oxide and histone deacetylases: A new relationship between old molecules. Commun Integr Biol (2009) 0.90
The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo. J Hematol Oncol (2015) 0.89
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells. Mol Immunol (2014) 0.88
Chromatin-remodelling proteins of the pea aphid, Acyrthosiphon pisum (Harris). Insect Mol Biol (2010) 0.88
Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. PLoS One (2012) 0.86
Requirement of a novel splicing variant of human histone deacetylase 6 for TGF-beta1-mediated gene activation. Biochem Biophys Res Commun (2010) 0.86
Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis. Mol Cell Biol (2011) 0.86
Microtubule stabilization by Mdp3 is partially attributed to its modulation of HDAC6 in addition to its association with tubulin and microtubules. PLoS One (2014) 0.85
Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanisms. Cell Death Dis (2013) 0.84
Histone deacetylase expression patterns in developing murine optic nerve. BMC Dev Biol (2014) 0.83
KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ (2015) 0.83
Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. Br J Cancer (2008) 0.82
Prospects for the development of epigenetic drugs for CNS conditions. Nat Rev Drug Discov (2015) 0.82
Heteromeric p97/p97R155C complexes induce dominant negative changes in wild-type and autophagy 9-deficient Dictyostelium strains. PLoS One (2012) 0.82
Acetylation and deacetylation--novel factors in muscle wasting. Metabolism (2012) 0.82
Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression. Oncotarget (2016) 0.81
TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function. J Biol Chem (2013) 0.81
Down-regulation of deacetylase HDAC6 inhibits the melanoma cell line A375.S2 growth through ROS-dependent mitochondrial pathway. PLoS One (2015) 0.81
Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells. Cancer Biol Ther (2014) 0.81
Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation. FASEB J (2014) 0.80
STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis. JAKSTAT (2013) 0.80
Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease. Clin Epigenetics (2015) 0.80
Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells. Br J Cancer (2014) 0.79
Aggresome formation is regulated by RanBPM through an interaction with HDAC6. Biol Open (2014) 0.79
RhoB upregulation leads to either apoptosis or cytostasis through differential target selection. Endocr Relat Cancer (2015) 0.78
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment. J Exp Clin Cancer Res (2014) 0.78
The Role of Histone Deacetylase 6 in Synaptic Plasticity and Memory. Cell Rep (2017) 0.77
Characterization of RanBPM molecular determinants that control its subcellular localization. PLoS One (2015) 0.77
Role of Exchange Protein Activated by cAMP 1 in Regulating Rates of Microtubule Formation in Cystic Fibrosis Epithelial Cells. Am J Respir Cell Mol Biol (2015) 0.77
Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
The Guanine nucleotide exchange factor kalirin-7 is a novel synphilin-1 interacting protein and modifies synphilin-1 aggregate transport and formation. PLoS One (2012) 0.76
HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells. Exp Biol Med (Maywood) (2015) 0.75
Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo. Sci Rep (2017) 0.75
Therapeutic effects of histone deacetylase inhibitors in a murine asthma model. Inflamm Res (2016) 0.75
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms. Cancer Cell Int (2013) 0.75
Action mechanisms of histone deacetylase inhibitors in the treatment of hematological malignancies. Cancer Sci (2016) 0.75
HDAC6 and ovarian cancer. Int J Mol Sci (2013) 0.75
Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy. Pharmacol Ther (2017) 0.75
Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J Biol Chem (1999) 3.23
Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways. Mol Cell Biol (2001) 3.09
Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem (2001) 2.41
Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci U S A (2001) 2.23
Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm. Curr Biol (2000) 2.21
mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J Biol Chem (2000) 2.04
Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem (1997) 1.96
Regulated hyperacetylation of core histones during mouse spermatogenesis: involvement of histone deacetylases. Eur J Cell Biol (2000) 1.96
Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc Natl Acad Sci U S A (1992) 1.86
Higher concentrations of histone macroH2A in the Barr body are correlated with higher nucleosome density. Curr Biol (2000) 1.56
VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca(2+)-but not for GTP gamma S-induced insulin secretion. EMBO J (1995) 1.56
The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J Biol Chem (2001) 1.52
Generation of microtubule stability subclasses by microtubule-associated proteins: implications for the microtubule "dynamic instability" model. J Cell Biol (1985) 1.44
What do linker histones do in chromatin? Bioessays (1997) 1.34
Histone acetylation influences both gene expression and development of Xenopus laevis. Dev Biol (1994) 1.31
Epigenetic reprogramming of the male genome during gametogenesis and in the zygote. Reprod Biomed Online (2008) 1.26
Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene (2010) 1.24
Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry (1999) 1.16
Mutational analysis of VAMP domains implicated in Ca2+-induced insulin exocytosis. EMBO J (1996) 1.15
Membrane localization and biological activity of SNAP-25 cysteine mutants in insulin-secreting cells. J Cell Sci (2000) 1.01
Release of the 120 kDa component of the mouse neural cell adhesion molecule N-CAM from cell surfaces by phosphatidylinositol-specific phospholipase C. Neurosci Lett (1986) 1.00
Misregulation of histone acetylation in Sertoli cell-only syndrome and testicular cancer. Mol Hum Reprod (2003) 1.00
Sliding of STOP proteins on microtubules. Biochemistry (1984) 0.98
p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation. Oncogene (2006) 0.97
SNAP-25a and -25b isoforms are both expressed in insulin-secreting cells and can function in insulin secretion. Biochem J (1999) 0.96
Identification and characterization of alpha 3 beta 1 integrin on primary and transformed rat islet cells. Exp Cell Res (1997) 0.96
Transient expression of botulinum neurotoxin C1 light chain differentially inhibits calcium and glucose induced insulin secretion in clonal beta-cells. FEBS Lett (1997) 0.93
Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol Cell Biol (2000) 0.91
HLA DQA1 genes generate multiple transcripts by alternative splicing and polyadenylation of the 3' untranslated region. Tissue Antigens (2004) 0.90
Regulation of histone H1(0) accumulation during induced differentiation of murine erythroleukemia cells. J Mol Biol (1991) 0.89
Histone acetylation-mediated chromatin compaction during mouse spermatogenesis. Ernst Schering Res Found Workshop (2006) 0.89
Developmentally regulated activity of CRM1/XPO1 during early Xenopus embryogenesis. J Cell Sci (2000) 0.88
Sliding of STOP proteins on microtubules: a model system for diffusion-dependent microtubule motility. Ann N Y Acad Sci (1986) 0.86
Induction of H1(0)-gene expression in B16 murine melanoma cells. Eur J Biochem (1992) 0.86
[Spermiogenesis: histone acetylation triggers male genome reprogramming]. Gynecol Obstet Fertil (2009) 0.86
Two mRNA species encoding the differentiation-associated histone H1(0) are produced by alternative polyadenylation in mouse. Eur J Biochem (1994) 0.85
Differential remodeling of the HIV-1 nucleosome upon transcription activators and SWI/SNF complex binding. J Mol Biol (2000) 0.85
A new splicing acceptor site and poly(A)+ sequence signal within DQA1*0401 and DQA1*0501 mRNA 3'UTR contribute to increase the extraordinary diversity of mRNA isoforms. Immunogenetics (2005) 0.83
The evolution of the differentiation-specific histone H1 gene basal promoter. J Mol Evol (1997) 0.83
Cell cycle-related accumulation of H1(0) mRNA: induction in murine erythroleukemia cells. Exp Cell Res (1991) 0.81
Relationship between core histone acetylation and histone H1(0) gene activity. Eur J Biochem (1994) 0.80
UV laser footprinting and protein-DNA crosslinking. Application to chromatin. Methods Mol Biol (1999) 0.79
Ultraviolet laser footprinting of histone H1(0)-four-way junction DNA complexes. Biochemistry (1999) 0.79
Accumulation of histone H1(0) during early Xenopus laevis development. Exp Cell Res (1995) 0.78
[Organizing the sperm nucleus]. Gynecol Obstet Fertil (2004) 0.78
A specific CBP/p300-dependent gene expression programme drives the metabolic remodelling in late stages of spermatogenesis. Andrology (2014) 0.78
In vivo analysis of HLA-DQ gene expression in heterozygous cell lines. Immunogenetics (1999) 0.77
Developmentally regulated chromatin acetylation and histone H1(0) accumulation. Int J Dev Biol (1995) 0.77
Characterization of the two H1(zero)-encoding genes from Xenopus laevis. Gene (1997) 0.77
Differential recognition of histone H10 by monoclonal antibodies during cell differentiation and the arrest of cell proliferation. J Biol Chem (1998) 0.76
[Epigenetics of the sperm cell]. Gynecol Obstet Fertil (2006) 0.76
Variation of H1(0) content throughout the cell cycle in regenerating rat liver. Exp Cell Res (1995) 0.75
S-phase-dependent action of cycloheximide in relieving chromatin-mediated general transcriptional repression. Biochem J (1998) 0.75
Characterization of a mutated p53 exhibiting a cell cycle-related nuclear translocation. Int J Oncol (1994) 0.75
Seric factors influence cell cycle modifications during commitment of murine erythroleukemia cells to differentiation. Cytometry (1992) 0.75
In situ analysis of chromatin proteins during development and cell differentiation using flow cytometry. Methods Mol Biol (1999) 0.75
Informations on the active site of palmito polyphenol oxidase. C R Acad Sci III (1995) 0.75
[Epigenetic perturbations and cancer: innovative therapeutic strategies against cancer]. Bull Cancer (2010) 0.75
A new human transporter associated with antigen processing alleles encodes a large C-terminal protein domain. Immunogenetics (1997) 0.75
Recovery of RNA from flow-sorted fixed cells. Cytometry (1990) 0.75
Comparison of TAP2 frequencies in type 1 diabetes patients and healthy controls from three ethnic groups indicates an African origin for the TAP2 G allele. Eur J Immunogenet (2003) 0.75